Personalized compounded versions for individual patients may still be available through licensed providers, but the regulatory environment is stricter than for semaglutide
100% of participants on the 8 mg and 12 mg doses in Phase 2 achieved at least 5% weight loss
Why stopping and starting can be risky For many patients, stopping is not really a choice
The blueberry anthocyanin contents, mainly malvidin, malvidin-3-glucoside, and malvidin-3-galactoside, can decrease oxidative stress in human retinal pigment epithelial cells caused by H 2 O 2 by reducing ROS and malondialdehyde levels, and increasing superoxide dismutase, catalase, and glutathione peroxidase levels [239]
Patients on tirzepatide were twice as likely to lose at least 25% of their body weight, and nearly one in five (19.7%) lost 30% or more, compared to fewer than one in fourteen (6.9%) on semaglutide.[1] Both medications also improved blood pressure, blood sugar, and cholesterol levels, with greater improvements seen in the tirzepatide group, which tracked with the larger weight reduction.[1] The safety profiles were similar
SapuntsovaSLebedkoOShchetkinaMFleyshmanMKozulinETimoshinS
